DOXORUBICIN HYDROCHLORIDE LIPOSOME

DOXORUBICIN HYDROCHLORIDE LIPOSOME was reported 85 times

DOXORUBICIN HYDROCHLORIDE LIPOSOME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COINFECTION 1 0.0145
1 GRANULOMATOUS LYMPHADENITIS 1 0.0053
2 SCROTAL ULCER 1 0.0038
3 ACUTE HEPATITIS B 1 0.0030
4 SKIN TURGOR DECREASED 1 0.0026
5 HEPATORENAL FAILURE 1 0.0017
6 GALLBLADDER POLYP 1 0.0013
7 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
8 BONE MARROW FAILURE 17 0.0008
9 TUMOUR PAIN 1 0.0008
10 FANCONI SYNDROME 1 0.0007
11 REGURGITATION 2 0.0006
12 GRANULOCYTOPENIA 3 0.0005
13 ORAL PRURITUS 1 0.0004
14 BREATH ODOUR 1 0.0004
15 PARAPLEGIA 1 0.0003
16 MYELOSUPPRESSION 12 0.0003
17 CARDIAC DYSFUNCTION 1 0.0003
18 PNEUMONIA FUNGAL 1 0.0003
19 CYSTITIS HAEMORRHAGIC 1 0.0002
20 NECROSIS 1 0.0002
21 NEUTROPHIL COUNT DECREASED 7 0.0002
22 DERMATITIS ACNEIFORM 1 0.0002
23 CHOLECYSTITIS CHRONIC 1 0.0001
24 ACIDOSIS 1 0.0001
25 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
26 HAEMATEMESIS 3 0.0001
27 CIRCULATORY COLLAPSE 2 0.0001
28 CARDIOTOXICITY 1 0.0001
29 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
30 END STAGE RENAL DISEASE 2 0.0001
31 PNEUMONIA BACTERIAL 1 0.0001
32 AGRANULOCYTOSIS 2 0.0001
33 LEUKAEMIA 1 0.0001
34 HAEMATOTOXICITY 1 0.0001
35 NEUTROPHIL COUNT INCREASED 1 0.0001
36 MOUTH ULCERATION 2 0.0001
37 NEPHROPATHY TOXIC 1 0.0001
38 MYOCARDIAL ISCHAEMIA 1 0.0001
39 NEOPLASM PROGRESSION 3 0.0001
40 ELECTROLYTE IMBALANCE 1 0.0001
41 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
42 CYTOPENIA 1 0.0001
43 MUCOSAL INFLAMMATION 2 0.0001
44 TACHYPNOEA 1 0.0001
45 ACUTE HEPATIC FAILURE 1 0.0001
46 BLOOD COUNT ABNORMAL 1 0.0001
47 CYANOSIS 1 0.0001
48 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
49 DRUG ERUPTION 1 0.0001
50 PLATELET COUNT DECREASED 6 0.0001
51 RESPIRATORY FAILURE 4 0.0001
52 HEPATIC FUNCTION ABNORMAL 2 0.0001
53 PULMONARY FIBROSIS 1 0.0001
54 FULL BLOOD COUNT DECREASED 1 0.0000
55 TASTE DISORDER 1 0.0000
56 MELAENA 1 0.0000
57 SHOCK 1 0.0000
58 HYPOKALAEMIA 2 0.0000
59 DYSPHAGIA 4 0.0000
60 LIVER INJURY 1 0.0000
61 ABDOMINAL PAIN LOWER 1 0.0000
62 GASTROINTESTINAL DISORDER 3 0.0000
63 INFUSION RELATED REACTION 2 0.0000
64 FEBRILE NEUTROPENIA 2 0.0000
65 SKIN DISORDER 1 0.0000
66 URINARY RETENTION 1 0.0000
67 INFECTION 4 0.0000
68 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
69 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
70 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
71 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
72 TACHYCARDIA 2 0.0000
73 NEUTROPENIA 3 0.0000
74 LEUKOPENIA 1 0.0000
75 HAEMOGLOBIN DECREASED 2 0.0000
76 THROMBOCYTOPENIA 2 0.0000
77 STOMATITIS 1 0.0000
78 ILL-DEFINED DISORDER 1 0.0000
79 FEELING HOT 1 0.0000
80 HEPATIC ENZYME INCREASED 1 0.0000
81 PYREXIA 5 0.0000
82 CHEST PAIN 2 0.0000
83 VOMITING 5 0.0000
84 NEUROPATHY PERIPHERAL 1 0.0000
85 CHEST DISCOMFORT 1 0.0000
86 HAEMORRHAGE 1 0.0000
87 PNEUMONIA 3 0.0000
88 INFLUENZA 1 0.0000
89 CHILLS 1 0.0000
90 OEDEMA PERIPHERAL 1 0.0000
91 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
92 NAUSEA 6 0.0000
93 DRY SKIN 1 0.0000
94 ABDOMINAL DISCOMFORT 1 0.0000
95 MYALGIA 1 0.0000
96 HYPERSENSITIVITY 1 0.0000
97 PRODUCT USE ISSUE 1 0.0000
98 PRURITUS 2 0.0000
99 ALOPECIA 1 0.0000
100 ERYTHEMA 1 0.0000
101 CONSTIPATION 1 0.0000
102 OFF LABEL USE 4 0.0000
103 MALAISE 2 0.0000
104 DECREASED APPETITE 1 0.0000
105 BACK PAIN 1 0.0000
106 DYSPNOEA 2 0.0000
107 ANXIETY 1 0.0000
108 ASTHENIA 1 0.0000
109 ARTHRALGIA 1 0.0000
110 RASH 1 0.0000
111 PAIN 1 0.0000
112 DIARRHOEA 1 0.0000
113 DRUG INEFFECTIVE 2 0.0000